Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/135667
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
| Type: | Journal article |
| Title: | Evaluating study designs and treatment outcomes of antidepressant pharmacogenetic clinical trials - Challenges and future perspectives. A critical review |
| Author: | Minelli, A. Barlati, S. Baune, B.T. |
| Citation: | European Neuropsychopharmacology, 2022; 59:68-81 |
| Publisher: | Elsevier BV |
| Issue Date: | 2022 |
| ISSN: | 0924-977X 1873-7862 |
| Statement of Responsibility: | Alessandra Minelli, Stefano Barlatic, Bernhard T Baunee, European College of Neuropsychopharmacology, ECNP, Pharmacogenomics, Transcriptomics Network |
| Abstract: | Abstract not available |
| Keywords: | Major depressive disorder; Randomized controlled trial; Remission |
| Rights: | © 2022 Elsevier B.V. and ECNP. All rights reserved. |
| DOI: | 10.1016/j.euroneuro.2022.04.007 |
| Grant ID: | NHMRC |
| Published version: | http://dx.doi.org/10.1016/j.euroneuro.2022.04.007 |
| Appears in Collections: | Psychiatry publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.